KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Invested Capital (2016 - 2025)

Historic Invested Capital for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $2.4 billion.

  • Exact Sciences' Invested Capital fell 4.98% to $2.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.4 billion, marking a year-over-year decrease of 4.98%. This contributed to the annual value of $2.4 billion for FY2025, which is 4.98% down from last year.
  • Latest data reveals that Exact Sciences reported Invested Capital of $2.4 billion as of Q4 2025, which was down 4.98% from $2.5 billion recorded in Q3 2025.
  • In the past 5 years, Exact Sciences' Invested Capital registered a high of $3.6 billion during Q1 2021, and its lowest value of $2.4 billion during Q1 2025.
  • Its 5-year average for Invested Capital is $3.0 billion, with a median of $3.2 billion in 2023.
  • Its Invested Capital has fluctuated over the past 5 years, first surged by 5153.46% in 2021, then crashed by 2481.94% in 2024.
  • Exact Sciences' Invested Capital (Quarter) stood at $3.4 billion in 2021, then decreased by 10.17% to $3.0 billion in 2022, then grew by 5.0% to $3.2 billion in 2023, then dropped by 24.82% to $2.4 billion in 2024, then fell by 0.05% to $2.4 billion in 2025.
  • Its last three reported values are $2.4 billion in Q4 2025, $2.5 billion for Q3 2025, and $2.5 billion during Q2 2025.